← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-01-19

Drug application

FDA Application #

ANDA207101

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN SUCCINATE

Generic name

SUMATRIPTAN

Active ingredients

SUMATRIPTAN SUCCINATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2023-01-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown